IRIS

Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study

DE FERRARI, GAETANO;SCHWARTZ, PETER;DUSI, VERONICA;
2015-01-01
2015
HEART RHYTHM
WOS:000353333100007
2-s2.0-84928619211
Inglese
12
5
872
878
7
25602175
Antiarrhythmic drug; Atrial fibrillation; Atrial flutter; Cardioversion; Electrophysiology; Randomized controlled trial; Ranolazine; Aged; Cardiovascular Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Atrial Fibrillation; Electric Countershock; Ranolazine; Cardiology and Cardiovascular Medicine; Physiology (medical)
http://www.elsevier.com/inca/publications/store/7/0/2/3/3/3/index.htt
20
info:eu-repo/semantics/article
262
DE FERRARI, Gaetano; Maier, Ls; Mont, L; Schwartz, Peter; Simonis, G; Leschke, M; Gronda, E; Boriani, G; Darius, H; Guillamón Torán, L; Savelieva, I; ...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1165624
Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 68
  • ???jsp.display-item.citation.isi??? 66
social impact